Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC – Get Free Report) shares dropped 1.4% on Monday . The company traded as low as $0.39 and last traded at $0.4370. Approximately 449,442 shares traded hands during trading, an increase of 1,886% from the average daily volume of 22,626 shares. The stock had previously closed at $0.4434.
Bellevue Life Sciences Acquisition Stock Down 1.4%
The business’s 50 day moving average price is $0.55 and its 200-day moving average price is $0.60.
About Bellevue Life Sciences Acquisition
Bellevue Life Sciences Acquisition Corp. (NASDAQ: BLAC) is a special purpose acquisition company organized as a Delaware corporation. The company completed its initial public offering in 2021, raising gross proceeds to pursue a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more life sciences businesses.
BLAC’s principal activity is to identify and complete a business combination with a target operating company in the life sciences sector.
Featured Stories
Receive News & Ratings for Bellevue Life Sciences Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellevue Life Sciences Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
